InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Sullivan Lynne Marie, Chief Financial Officer. Insider active across 2 companies, notably Unity Biotechnology, Inc.. Cumulatively, 5 filings have been logged. Total volume traded: €84k. The latest transaction was disclosed on 9 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
050,000 shares0
Common Stock, $0.0001 par value
SEC:0000899243-22-006446:0·
€42,20812,500 shares@ €3.3767100.0% of flow
Common Stock
SEC:0001213900-21-039439·
Ideal exit: 24 Apr 2022 (T+270)
€42,20812,500 shares@ €3.37670.32% mcap50.0% of flow
Common Stock
SEC:0001213900-21-039439:0·
Ideal exit: 24 Apr 2022 (T+270)
030,833 shares0
Common Stock, $0.0001 par value
SEC:0000899243-21-026230:0·
030,833 shares0
Common Stock, $0.0001 par value
SEC:0000899243-21-026230·
5 of 5 declarations
About Sullivan Lynne Marie
Lynne Marie Sullivan is the Chief Financial Officer and Head of Corporate Development at Unity Biotechnology, Inc. and BiomX Inc. She oversees financial management and strategic development initiatives. Her expertise is essential for the growth of both companies.
